Lab Techniques: PCR, Blotting, CRISPR
Amplify, probe, sort, and edit nucleic acids
PCR and its variants
Ingredients. The polymerase chain reaction copies a chosen DNA segment in a tube. It needs the template DNA, two primers that flank the target, a heat-stable DNA polymerase (Taq), and deoxynucleotides (dNTPs).
- Denaturation, ~95 °CHeat separates the two DNA strands
- Annealing, ~55 °CPrimers bind their complementary template sites
- Extension, ~72 °CTaq synthesizes the new strands from the primers
- Repeat 20–40 cyclesEach cycle doubles the target: exponential amplification
Why Taq. Taq polymerase comes from Thermus aquaticus, a hot-spring bacterium, so it survives the repeated ~95 °C denaturation steps. It lacks proofreading activity, so it is chosen for heat stability, not fidelity.
Reading the result. Products are usually visualized by gel electrophoresis, which separates DNA fragments by size.
RT-PCR. Reverse transcriptase first copies RNA (e.g., mRNA) into complementary DNA (cDNA), which PCR then amplifies. This is how RNA viruses such as SARS-CoV-2, HIV, and HCV are detected.
Quantitative (real-time) PCR. Fluorescence is measured every cycle; the sooner the signal rises, the more starting template was present. It quantifies nucleic acid, as in viral load testing or monitoring BCR-ABL transcripts in CML.
Do not mix up the abbreviations: RT-PCR (reverse transcription) lets you amplify RNA; real-time/quantitative PCR measures how much is there. The two are often combined.
Blotting: SNoW DRoP
General scheme. Molecules are separated by size on a gel, transferred ("blotted") to a membrane, and detected with a labeled probe. Mnemonic SNoW DRoP: Southern = DNA, Northern = RNA, Western = Protein.
| Blot | Detects | Probe | Classic uses |
|---|---|---|---|
| Southern | DNA (restriction-cut fragments) | Labeled DNA probe | Gene rearrangements; trinucleotide repeat expansions (Huntington CAG, fragile X CGG) |
| Northern | RNA | Labeled nucleic-acid probe | Sizes and quantifies mRNA: whether and how much a gene is expressed in a tissue |
| Western | Protein (separated by SDS-PAGE) | Antibody | Lyme disease confirmation after a positive ELISA; historically, HIV confirmation |
Southern blot for repeat disorders. Because it directly sizes large DNA fragments, and can be paired with methylation-sensitive restriction enzymes, the Southern blot is the classic way to confirm a fragile X full mutation of several hundred CGG repeats with abnormal methylation. The Northern blot is simply its RNA analog.
Antibody-based assays: ELISA and flow cytometry
ELISA. An antibody linked to an enzyme produces a color change when its target is present; the assay can detect either an antigen or an antibody in a sample. Being highly sensitive, it serves as the HIV screening test and detects many autoantibodies.
Flow cytometry. Cells tagged with fluorophore-linked antibodies pass one by one through a laser: forward scatter reflects size, side scatter reflects granularity, and fluorescence identifies surface markers. Uses include immunophenotyping leukemias and lymphomas, CD4 counts in HIV, and diagnosing paroxysmal nocturnal hemoglobinuria (PNH) by the absence of the GPI-anchored proteins CD55 and CD59.
| Feature | ELISA | Western blot | Flow cytometry |
|---|---|---|---|
| Sample | Fluid; detects antigen or antibody | Proteins separated by SDS-PAGE | Intact cells in suspension |
| Readout | Enzyme-driven color change | Antibody-labeled bands | Fluorescence and light scatter per cell |
| Typical role | Sensitive screening (HIV) | Confirms a specific protein (Lyme) | Immunophenotyping, CD4 count, PNH |
Cytogenetics: karyotype, FISH, microarrays
Karyotype. Dividing cells are arrested in metaphase, stained, and their chromosomes ordered by size and banding pattern. It detects aneuploidy (trisomy 21), large deletions, and translocations but cannot resolve microdeletions smaller than about 5 Mb.
FISH. Fluorescence in situ hybridization binds a fluorescent DNA probe to one chosen chromosomal region. It reveals microdeletions (DiGeorge 22q11), translocations (BCR-ABL, t(9;22)), and gene amplification (HER2) — changes too small for a karyotype — and works on nondividing (interphase) cells.
DNA microarrays. Sample nucleic acid hybridizes to thousands of chip-bound probes. Expression arrays profile mRNA to classify tumors; SNP arrays genotype variants for genome-wide association studies (GWAS) and detect copy-number changes and microdeletions across the whole genome. Balanced rearrangements, which do not change copy number, are missed.
| Feature | Karyotype | FISH | SNP / chromosomal microarray |
|---|---|---|---|
| Scope | Whole genome, low resolution | One targeted locus | Whole genome, high resolution |
| Best for | Aneuploidy, large rearrangements | Known microdeletion, translocation, amplification | Copy-number changes anywhere; genotyping |
| Misses | Deletions under ~5 Mb | Anything outside the probe | Balanced translocations |
Suspected microdeletion — for example, a child with a conotruncal heart defect, hypocalcemia, and recurrent infections (DiGeorge, 22q11.2): order FISH or a chromosomal microarray, not a standard karyotype.
Genome editing with CRISPR/Cas9
Mechanism. A guide RNA base-pairs with the matching genomic sequence and directs the Cas9 nuclease there; Cas9 cuts only where the target lies next to a short PAM sequence. The guide RNA supplies specificity; Cas9 is the molecular scissors.
- TargetingGuide RNA pairs with the chosen DNA sequence
- CuttingCas9 makes a double-strand break beside the PAM
- Repair by NHEJError-prone joining leaves small insertions or deletions: gene knockout
- Repair by HDRA supplied donor template is copied in: precise knock-in
Clinical use. The same double-strand break repair pathways used by cells after DNA damage are harnessed here. Ex vivo editing of a patient's own hematopoietic stem cells underlies gene-editing therapy for sickle cell disease, which works by reactivating fetal hemoglobin production.